Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome Among Patients with History of Congestive Heart Failure (From the ATLAS-ACS-2 TIMI-51 Trial)
Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome Among Patients with History of Congestive Heart Failure (From the ATLAS-ACS-2 TIMI-51 Trial)
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started